This is true...all of these recent moves point to extreme confidence by management that they will be successful in getting IDE approval from FDA. Depending on how low share price drops before next positive announcement on IDE, I might buy another couple hundred thousand shares.
Per most recent downdates, they haven't figured out yet how to manufacture Radiogel and MK remains distracted with hopelessly unprofitable IsoPet. That's the sad reality at moment.
News 
Market Data 
Discover 
